Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
ADELE CIRONE OLIVA
AddedMar 31, 2024
UpdatedMay 31, 2026
ADELE CIRONE OLIVA

ADELE CIRONE OLIVA

Board Member, Tela Bio

Crunchbase

ADELE CIRONE OLIVA's Career

Tela Bio
Tela Bio

Malvern, PA, US

Board Member· Board
Onkos Surgical
Onkos Surgical

Parsippany-Troy Hills, NJ, US

Board Member· Board
NovaSom
NovaSom

Glen Burnie, MD, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

ADELE CIRONE OLIVA's Career

Tela Bio
Tela Bio

Malvern, PA, US

Board Member· Board
Onkos Surgical
Onkos Surgical
Series B$85.2M892015Parsippany-Troy Hills, NJ, US
Board Member· Board

Leadership at Onkos Surgical

Antony KoblishAntony KoblishBoard Member
Patrick TreacyPatrick TreacyCo-Founder
Paul TouheyPaul TouheyBoard Member
Stephen BlochStephen BlochBoard Member

Similar to Onkos Surgical

CairnSurgicalCairnSurgicalLebanon, NH, USMedical Devicesest. 2017CairnSurgicalLebanon, NH, US · est. 2017

CairnSurgical: Innovating patient-specific medical devices for precise cancer surgery.

Series A · $3.3M16
OnPoint SurgicalOnPoint SurgicalBedford, MA, USSurgical Guidanceest. 2017OnPoint SurgicalBedford, MA, US · est. 2017

OnPoint Surgical provides augmented reality tech for precise orthopedic and neurosurgical procedures.

Seed · $200k19
OsseoPrint 3DOsseoPrint 3DMillburn, NJ, USBone Scaffoldsest. 2016OsseoPrint 3DMillburn, NJ, US · est. 2016

Osseoprint 3D designs and 3D prints patient-specific bone scaffolds for efficient, precise bone reconstruction surgeries.

Angel · $115k7
RevOrthoRevOrthoGreat Neck, NY, USMedical Devicesest. 2013RevOrthoGreat Neck, NY, US · est. 2013

RevOrtho, a NY-based medical device company, innovates in orthopedic technology for enhanced implants and individualized solutions.

Angel · $50k2
NovaSom
NovaSom
Series B$114.6M1251992Glen Burnie, MD, US
Board Member· Board

Leadership at NovaSom

Eran NadavEran NadavBoard Member
Jim DatinJim DatinBoard Member
Jack StoddardJack StoddardBoard Member
Brian SiskoBrian SiskoBoard Member
D. Keith GrossmanD. Keith GrossmanBoard Member
John SpitznagelJohn SpitznagelCEO

ADELE CIRONE OLIVA's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to ADELE CIRONE OLIVA

Matt RiekeMatt RiekeBoard Member · Asensus SurgicalJérôme ChevalierJérôme ChevalierBoard Member · CoravinClem O'DonnellClem O'DonnellBoard Member · ServiceaideChris AdamsChris AdamsBoard Member · GoodRxDean NelsonDean NelsonBoard Member · Xsell TechnologiesChris StallmanChris StallmanBoard Member · Karamba Security